Complement and Renal Transplantation: From Donor to Recipient

@article{Damman2008ComplementAR,
  title={Complement and Renal Transplantation: From Donor to Recipient},
  author={Jeffrey Damman and Theo A. Schuurs and Rutger J Ploeg and Marc A.J. Seelen},
  journal={Transplantation},
  year={2008},
  volume={85},
  pages={923-927}
}
Long-term kidney graft survival is affected by different variables including donor condition, ischemia-reperfusion injury, and graft rejection during the transplantation process. The complement system is an important mediator of renal ischemia-reperfusion injury and in rejecting allografts. However, donor complement C3 seems to be crucial in renal transplantation-related injury as renal injury is attenuated in C3 deficient kidney grafts. Interestingly, before ischemia-reperfusion induced C3… 
Ischemia-reperfusion injury in kidney transplantation.
Ischemia-reperfusion injury to the kidney is a complex pathophysiological process that has importance during transplantation as it affects graft function and survival. It starts with the
Role of Complement System in Kidney Transplantation: Stepping From Animal Models to Clinical Application
TLDR
The updated understanding of the complement system in kidney transplantation is provided and the existing and upcoming attempts to improve allograft outcomes in animal models and in the clinical setting by targeting the complement System are introduced.
Complement‐mediated inflammation and injury in brain dead organ donors
The Role of Complement in Organ Transplantation
TLDR
Therapeutic complement inhibitors may be effective for protecting transplanted organs from several causes of inflammatory injury and several anti-complement drugs have shown promise in selected patients, but the role of these drugs in transplantation medicine requires further study.
Clinical analysis of perioperative complement activity during ischemia/reperfusion injury following renal transplantation.
TLDR
A role for the complement cascade in delayed graft function development is supported and perioperative measurements of C5b-9/membrane attack complex are highlighted as promising potential clinical markers of post-transplant renal allograft function.
The effect of ischemia/reperfusion on the kidney graft
TLDR
It is of particular importance in kidney transplantation to understand the underlying mechanisms and effects of ischemia/reperfusion on the graft as this knowledge also opens strategies to prevent or treat ischemial injury after transplantation in order to improve graft outcome.
Complement in renal transplantation: The road to translation
Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation.
  • J. Damman, W. Nijboer, +6 authors M. Seelen
  • Medicine, Biology
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2011
TLDR
Targeting renal APPs in brain-dead donors, especially complement C3, may improve transplant outcome, as C3 expression is associated with a worse allograft function early after transplantation.
Donor Brain Death Exacerbates Complement-Dependent Ischemia/Reperfusion Injury in Transplanted Hearts
TLDR
BD exacerbates posttransplantation cardiac ischemia/reperfusion injury in mice and humans and decreases survival of mouse allografts, and targeted complement inhibition in recipients of BD donor hearts ameliorates BD-exacerbated ischemIA/rePerfusions injury.
Targeted donor complement blockade after brain death prevents delayed graft function in a nonhuman primate model of kidney transplantation
  • J. S. Danobeitia, Tiffany J Zens, +20 authors L. Fernandez
  • Medicine, Biology
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2020
TLDR
It is indicated that donor‐management targeting complement activation prevents the development of delayed graft function in BD‐induced renal injury and postulate complement blockade as a promising strategy for the prevention of DGF after transplantation.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 86 REFERENCES
Influence of donor brain death on chronic rejection of renal transplants in rats.
TLDR
Donor BD accelerates the progression of long-term changes associated with kidney Tx and is an important risk factor for chronic rejection, which explains in part the clinically noted difference in long- term function between organs from cadaver and living sources.
Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.
TLDR
The data suggest that complement activation and renal allograft rejection are independent of the classical and lectin pathways in these models, implying that in the absence of these pathways the alternative pathway is the main trigger for complement-mediated rejection.
Accelerated Rejection of Renal Allografts From Brain-Dead Donors
TLDR
Donor brain death is a significant risk factor for peripheral organs used for transplantation because the activated state of such organs appears to trigger host immune mechanisms that accelerate the process of acute rejection.
Determinants of graft survival after renal transplantation.
TLDR
It is suggested that a combination of immediate graft function, prevention of acute rejection by appropriate early immunosuppressive therapy, and acceptable DR match enhances cadaveric graft survival.
Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat.
TLDR
There was a significant reduction in infiltrating leukocytes by day 5 after transplant, and complement inhibition delayed the time to reach a histologically defined end point of graft survival from 5 days in controls to 9 days in the sCR1-treated group, implying that the vascular and cell-mediated injury arises, in part, from complement activation.
Lack of a Functional Alternative Complement Pathway Ameliorates Ischemic Acute Renal Failure in Mice 1
TLDR
It is demonstrated that complement activation in the kidney after I/R occurs exclusively via the alternative pathway, and that selective inhibition of this pathway provides protection to the kidneys from ischemic ARF.
Vascular deposition of complement‐split products in kidney allografts with cell‐mediated rejection
TLDR
Despite negative results in the crossmatch before transplantation and paucity of immunoglobulins in transplant biopsies, antibodies directed against endothelial cell antigens should be considered as a possible cause of classical complement activation.
Complement inhibition by soluble complement receptor type 1 improves microcirculation after rat liver transplantation.
TLDR
It is concluded that complement inhibition by sCR1 represents an effective treatment to prevent reperfusion injury in liver transplantation and further evidence that the complement system plays a decisive role in hepatic ischemia/reperfusion Injury.
B Cell Deficiency Confers Protection from Renal Ischemia Reperfusion Injury 1
TLDR
These data are the first demonstration of a pathogenic role for B cells in ischemic acute renal failure, with a serum factor as a potential underlying mechanism of action.
Allograft immune response with sCR1 intervention.
...
1
2
3
4
5
...